A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia

Neuroscience

Volumn 72, Issue 1, 1996, Pages 117-128

  Eberle Wang, K ^a   Lucki, I ^a   Chesselet, M F ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

1 (m chlorophenyl)piperazine; 5 hydroxytryptamine; Basal ganglia; Hyperkinesia; Orofacial dyskinesia; SDZ SER 082; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4,5,7A,8,9,10,11,11A OCTAHYDRO 10 METHYL 7H INDOLO[1,7 BC][2,6]NAPHTHYRIDINE; KETANSERIN; MESSENGER RNA; MESULERGINE; MIANSERIN; PINDOLOL; SEROTONIN 1C RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SPIPERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HISTOLOGY; NONHUMAN; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DYSKINESIA, DRUG-INDUCED; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MICROINJECTIONS; MOUTH; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; THALAMIC NUCLEI;

EID: 0029989555     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00548-X     Document Type: Article

References (51)

1. Albin R. L., Young A. B. and Penney J. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375.
2. Andersson U., Häggstöm E., Levin E. D., Bondesson U., Valverius M. and Gunne L. M. (1989) Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia. Movement Disorders 4, 37-46.
3. Aziz T. Z., Peggs M. A., Sambrook M. A. and Crossman A. R. (1991) Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Movement Disorders 6, 288-292.
4. Banks R., Brun P. and Chesselet M.-F. (1995) Oral dyskinesia induced by kainic acid lesions of the subthalamic nucleus in the rat. Soc. Neurosci. Abstr. 21, 1428.
5. Bergman H., Wichmann T. and Delong M. R. (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249, 1436-1438.
6. 1C receptors. Trends pharmac. Sci. 11, 181-182.
7. Delfs J. M. and Kelley A. E. (1990) The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 39, 59-67.
8. Delfs J. M. and Ciaramitaro V. M., Parry T. and Chesselet M.-F. (1995) Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. J. Neurosci. 15, 6562-6575.
9. DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285.
10. 1C receptor mRNA in the basal ganglia of rats. Soc. Neurosci. Abstr. 19, 132.
11. Elliot P. J., Walsh D. M., Close S. P., Higgins G. A. and Hayes A. G. (1990) Behavioral effects of serotonin agonists and antagonists in the rat and marmoset. Neuropharmacology 29, 949-956.
12. Ellison G. (1991) Spontaneous orofacial movements in rodents induced by long-term neuroleptic administration: a second opinion (letter; comment). Psychopharmacology 104, 404-408.
13. Féger J., Robledo P. and Renwart N. (1992) The subthalamic nucleus: new data, new questions. In The Basal Ganglia III (eds Bernardi G., Carpenter M. B., Chiara G. D., Morelli M. and Stanzione P.), pp. 99-108. Plenum Press, New York.
14. Fremeau R. T. Jr, Duncan G. E., Fornaretto M. G., Dearry A., Gingrich J. A., Breese G. R. and Caron M. G. (1991) Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. Proc. natn. Acad. Sci. U.S.A. 88, 3772-3776.
15. Ginefri-Gayet M. and Gayet J. (1992) Involvement of serotonin receptors in methionine sulfoximine-induced hypothermia. Eur. J. Pharmac. 217, 85-91.
16. Glennon R. A. (1987) Central serotonin receptors as targets for drug research. J. med. Chem. 30, 1-12.
17. Gong L., Kostrzewa R. M., Fuller R. N. and Perry K. W. (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J. Pharmac. exp. Ther. 261, 1000-1007.
18. Gunne L. M., Haggstrom J. E. and Sjoquist B. (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309, 347-349.
19. Hara C. and Ogawa N. (1986) Potentiation of haloperidol-induced catalepsy by beta-adrenoceptor antagonists in mice. Jap J. Pharmac. 42, 79-86.
20. 1C receptor mRNA in adult rat brain. Fedn Eur. biochem. Socs Lett. 247, 453-462.
21. Kelley A. E., Lang C. G. and Gauthier A. M. (1988) Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum. Psychopharmacologia 95, 556-559.
22. 1C receptors. Br. J. Pharmac. 94, 137-147.
23. 1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Br. J. Pharmac. 103, 2016-2020.
24. Kitai S. T. and Kita H. (1987) Anatomy and physiology of the subthalamic nucleus: a driving force of the basal ganglia. In The Basal Ganglia (eds Carpenter M. B. and Jayaraman A.), pp. 357-373. Plenum Pres, New York.
25. 1C receptors. Neurosci. Biobehav. Rev. 16, 95-105.
26. Korsgaard S., Gerlach J. and Christensson E. (1985) Behavioral aspects of serotonin-dopamine interaction in the monkey. Eur. J. Pharmac. 118, 245-252.
27. Levy A. D., See R. E., Levin E. D. and Ellison G. D. (1987) Neuroleptic induced oral movements in rats: methodological issues. Life Sci. 41, 1499-1506.
28. Lucki I., Ward H. R. and Frazer A. (1989) Effect of 1-(m-chlorophenyl) piperazine and 1-(m-trifluoromethyl) piperazine on locomotor activity. J. Pharmac. exp. Ther. 249, 155-164.
29. McDougle C. J., Goodman W. K., Leckman J. F. and Price L. H. (1993) The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. Psychiat. Clin. North Am. 16, 749-766.
30. Mengod G., Nguyen H., Le H., Waeber C., Lubbert H. and Palacios J. M. (1990) The distribution and the cellular localization of the serotonin 1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience 35, 577-591.
31. Middlemiss D. N. and Tricklebank M. D. (1992) Centrally active 5-HT receptor agonists and antagonists. Neurosci. Biobehav. Rev. 16, 75-82.
32. Mitchell I. J., Jackson A., Sambrook A. and Crossman A. R. (1985) Common neural mechanisms in experimental chorea and hemiballismus in the monkey. Evidence from 2-deoxyglucose autoradiography. Brain Res. 339, 346-350.
33. Mori S., Takino T., Yamada H. and Sano Y. (1985a) Immunohistochemical demonstration of serotonin nerve fibers in the subthalamic nucleus of the rat, cat and monkey. Neurosci. Lett. 62, 305-309.
34. 2C antagonist. Soc. Neurosci. Abstr. 19, 298.
35. Palkovits M., Brownstein M. and Saavedra J. M. (1974) Serotonin content of the brain stem nuclei in the rat. Brain Res. 80, 237-249.
36. Parent A. and Hazrati L. N. (1995) Functional-anatomy of the basal ganglia - 2. The place of the subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Rev. 20, 128-154.
37. Parry T. J., Eberle-Wang K., Lucki I. and Chesselet M.-F. (1994) Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Exp. Neurol. 128, 181-190.
38. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Orlando, FL.
39. Pazos A., Hoyer D. and Palacios J. M. (1984) The binding of serotonergic ligand to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmac. 106, 539-546.
40. Reynolds G. P. and Pearson S. J. (1987) Decreased glutamic acid and increased 5-hydroxytryptamine in Huntington's disease brain. Neurosci. Lett. 78, 233-238.
41. Rinvik E., Grofova I., Hammond C., Feger J. and Deniau J. M. (1979) A study of the afferent connections to the subthalamic nucleus in the monkey and the cat using the HRP technique. In Advances in Neurology (eds Poirer L. J., Sourkes T. L. and Bedard P. J.), Vol. 24, pp. 53-70. Raven Press, New York.
42. Rosengarten H., Schweitzer J. W. and Freidhoff A. J. (1983) Induction of oral dyskinesias in naive rats by D1 stimulation. Life Sci. 33, 2479-2482.
43. Ryan L. J. and Sanders D. J. (1993) Subthalamic nucleus lesion regularizes firing patterns in globus pallidus and substantia nigra pars reticulata neurons in rats. Brain Res. 626, 327-331.
44. Saavedra J. M. (1977) Distribution of serotonin and synthesizing enzymes in discrete areas of the brain. Fed. Proc. 36, 2134-2141.
45. Soubrié P., Reisine T. D. and Glowinski J. (1984) Functional aspects of serotonin transmission in the basal ganglia. A review and an in vitro approach using the push pull cannula technique. Neuroscience 13, 605-625.
46. Steinbusch H. W. M. (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat - cell bodies and terminals. Neuroscience 6, 557-618.
47. Stewart B. R., Jenner P. and Marsden C. D. (1989) Induction of purposeless chewing behavior in rats by 5-HT agonist drugs. Eur. J. Pharmac. 162, 101-107.
48. Tricklebank M. D. (1985) The behavioral response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. Trends pharmac. Sci. 6, 403-407.
49. Tzagournissakis M., Dermon C. R. and Savaki H. E. (1994) Functional metabolic mapping of the rat brain during unilateral electrical stimulation of the subthalamic nucleus. J. cerebr. Blood. Flow. Metab. 14, 132-144.
50. Waddington J. L., Youssef H. A., O'Boyle K. M. and Molloy A. G. (1986) A reappraisal of normal involuntary movements (tardive dyskinesia) in schizophrenia and other disorders: animal models and alternative hypotheses. In The Neurobiology of Dopamine Systems (eds Winlow W. and Markstein R.), pp. 266-286. Manchester University Press, Manchester.
51. Whittier J. R. (1947) Ballism and the subthalamic nucleus. Archs Neurol. Psychiat. 58, 672-692.